The conversion window in hepatocellular carcinoma: When resectability alone is not an indication for surgery
Drug Discoveries & Therapeutics · 31.10.2026 · 20 (5) · 360-364
DOI: 10.5582/ddt.2026.01068 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Discoveries & Therapeutics, erschienen am 31.10.2026. Verfasst von Weiping Zhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Hepatectomy. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
- National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
Zitieren
APA
Zhu, W., Wang, L., & Tang, W. (2026). The conversion window in hepatocellular carcinoma: When resectability alone is not an indication for surgery. Drug Discoveries & Therapeutics, 20(5), 360-364. https://doi.org/10.5582/ddt.2026.01068
Vancouver
Zhu W, Wang L, Tang W. The conversion window in hepatocellular carcinoma: When resectability alone is not an indication for surgery. Drug Discoveries & Therapeutics. 2026;20(5):360-364. doi:10.5582/ddt.2026.01068
BibTeX
@article{Zhu2026,
author = {Zhu, Weiping and Wang, Lu and Tang, Wei},
title = {The conversion window in hepatocellular carcinoma: When resectability alone is not an indication for surgery},
journal = {Drug Discoveries & Therapeutics},
year = {2026},
volume = {20},
number = {5},
pages = {360--364},
doi = {10.5582/ddt.2026.01068}
}
EUVIMED